Concepedia

Vasant Jadhav

VJ

Statistics

Publications

32

Citations

4.1K

H-Index

26

Active since

1996

Affiliations

Alnylam Pharmaceuticals (United States)(Current)

United States Military Academy

Vanderbilt University

Mirna Therapeutics (United States)

National Chemical Laboratory

Vasant Jadhav is an author at Alnylam Pharmaceuticals (United States) specializing in natural sciences, molecular biology, and medicine.

ORCID

Top concepts

Publications per year

1996–2024

32

Publications

32

Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs

Jennifer A. Lockridge, Lucinda Shaw, Karin S. Blanchard et al. · Nature Biotechnology · 2005 · 1.2K citations

, , +9

Advanced siRNA Designs Further Improve In Vivo Performance of GalNAc-siRNA Conjugates

Donald J. Foster, Christopher R. Brown, Sarfraz Shaikh et al. · Molecular Therapy · 2018 · 294 citations · Full text

Investigating the pharmacodynamic durability of GalNAc–siRNA conjugates

Christopher R. Brown, Swati Gupta, June Qin et al. · Nucleic Acids Research · 2020 · 265 citations · Full text

, , +15

Impact of enhanced metabolic stability on pharmacokinetics and pharmacodynamics of GalNAc–siRNA conjugates

Jayaprakash K. Nair, Husain Attarwala, Alfica Sehgal et al. · Nucleic Acids Research · 2017 · 258 citations · Full text

, , +16

Selection of GalNAc-conjugated siRNAs with limited off-target-driven rat hepatotoxicity

Maja M. Janas, Mark K. Schlegel, Carole E. Harbison et al. · Nature Communications · 2018 · 255 citations · Full text

1–5 of 32